AmpliVue

AmpliVue

AmpliVue

Product catalog summary
Overview: The document provides details about the AmpliVue GBS Assay, a molecular diagnostic tool for detecting Group B Streptococcus (GBS) using vaginal/rectal swabs. It emphasizes the ease of use, cost-effectiveness, and efficiency of the assay.
Specifications: The assay requires no specialized thermocycling equipment and minimal bench space, making it suitable for various laboratory settings. It is classified as CLIA Moderately Complex and uses a sealed, disposable cartridge to minimize contamination risks.
Procedure: The AmpliVue GBS Assay is available as a 16 Test Kit (Catalog #M202) and includes a control set for 20 reactions (Catalog #M116). The procedure involves using specific lysis and amplification blocks for optimal results.
Performance: The assay provides results in 80 minutes with less than 5 minutes of hands-on time after overnight enrichment. It has a sensitivity of 99.5% and specificity of 92.7%. The Negative Predictive Value is 99.8%, and the Positive Predictive Value is 79.0%.
Reagents and Scalability: The use of lyophilized reagents extends shelf life and reduces waste. The assay is scalable, allowing for flexible batch sizes without the need for capital investment.
Limitations: The assay is not for sale in the U.S., and there are some discordant results when compared to bacterial culture methods, which were further analyzed using an FDA-cleared molecular device.
See more

Catalog excerpts

AmpliVue-1

AjnpliVue Anytime, Anywhere Molecular Assays Implement anywhere ■ No specialized thermocycling equipment, minimal bench space ■ CLIA Moderately Complex ■ Sealed, disposable cartridge reduces risk of amplicon contamination and need for an isolation room Fast and easy anytime ■ Results in 80 minutes with less than 5 minutes hands-on time, after overnight enrichment ■ Intuitive workflow - can be run by any technician 24/7 ■ Simple results interpretation Cost effective ■ No capital investment ■ Built-in internal control ■ Scalable batch size ■ Lyophilized reagents extend shelf life, reduces waste and re-ordering Quidel | Molecular Diagnostics | quidel.com | 800.874.1517 | 858.552.1100

 Open the catalog to page 1
AmpliVue-2

Sample Preparation Dilution Tube *Fifty-two (52) discordant specimens (AmpliVue Positive/Bacterial Culture Negative) reported above were tested with an FDA-cleared molecular device for the detection of GBS, thirty-nine (39) of these specimens were positive for GBS, and thirteen (13) were negative. **The one (1) discordant specimen (AmpliVue Negative/Bacterial Culture Positive) reported above were tested with an FDA-cleared molecular device for the detection of GBS, and was negative. Prior to discordant analysis, the Negative Predictive Value was 99.8%, and the Positive Predictive Value was 79.0%....

 Open the catalog to page 2

All Quidel Eye Health catalogs and technical brochures

  1. QuickVue

    2  Pages

  2. Lyra

    2  Pages

  3. MicroVue C1

    1  Page

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.